01—Abstract
Summary
Summary of the 10-Q filed October 28, 2026. Cited figures are marked; the original filing is the authoritative source.
Markel Group Inc. reported net income to shareholders of $259.3 milliona for the quarter ended September 30, 2026, compared with $751.3 million in the same quarter of 2025, and $1.22 billion for the nine months ended September 30, 2026, compared with $1.53 billion a year earlier.
Quarterly results were pressured by a $280.9 millionb net investment loss, compared with a $432.9 million gain in the prior-year quarter, and by $74.6 million of net losses from the Middle East conflict. Total operating revenues rose to $4.16 billion for the quarter from $3.93 billion, and adjusted operating income was $707.4 million versus $621.0 million. Markel Insurance's combined ratio was 91.9% for the quarter and 92.5% for the nine months, and the company recorded a $205.3 million provision for expected credit losses tied to a capacity provider in bankruptcy within its State National fronting operations.
Balance sheet and capital activity were also notable. Total equity was $18.51 billionc at September 30, 2026, down from $18.60 billion at year-end 2025, as accumulated other comprehensive loss grew to $(720.7) million on unrealized losses in the fixed maturity portfolio. The company repurchased $685.3 million of common stock in the first nine months, and $832.6 million remained available under its $2 billion repurchase program.
Operating cash flow was $1.39 billiond for the nine months, down from $2.10 billion, reflecting a $240.9 million decline in premium collections from the run-off Global Reinsurance division. A subsequent event disclosed in the filing is an adverse development cover reinsurance agreement, entered into October 27, 2026, with Cavello Bay Reinsurance Limited, a subsidiary of Enstar Group Limited.
The agreement covers $4.8 billion of subject reserves, with Markel retaining the first $2.6 billion and providing $1.2 billion of coverage above that, in exchange for a $120 million risk premium. The transaction is expected to close in the fourth quarter of 2026, subject to regulatory approvals.
02—Key points
Key Highlights
- Net income to shareholders was $259.3 million for Q3 2026 versus $751.3 million in Q3 2025, reflecting a $280.9 million net investment loss in the quarter.
- Adjusted operating income rose to $707.4 million for the quarter from $621.0 million, led by Markel Insurance ($420.9 million) and Industrial ($131.1 million).
- Markel Insurance's combined ratio was 91.9% for the quarter and 92.5% for the nine months, with $150.6 million of nine-month net losses from the Middle East conflict.
- A $205.3 million provision for expected credit losses was recorded in the second quarter of 2026 on reinsurance recoverables from a bankrupt capacity provider in State National's fronting operations.
- Shareholders' equity was $18.51 billion at September 30, 2026, and accumulated other comprehensive loss increased to $(720.7) million from $(109.5) million at year-end 2025.
- Operating cash flow fell to $1.39 billion for the nine months from $2.10 billion, and the company repurchased $685.3 million of common stock.
- Subsequent to quarter end, Markel Insurance agreed to an adverse development cover with Enstar's Cavello Bay on $4.8 billion of subject reserves for a $120 million risk premium.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2026filed October 28, 2026Financial Statements
Q3 FY2026 against Q3 FY2025
| Line item | Q3 FY2026Q3 FY2025 | Change |
|---|---|---|
| Revenue | $4.16B$3.93B | +5.7% |
| Operating Expenses | $3.49B$3.36B | +4.1% |
| Operating Income | $383.23M$1.01B | −62.1% |
| Interest Expense | $50.86M$50.68M | +0.4% |
| Net Income | $259.25M$751.34M | −65.5% |
| EPS (Diluted) | $18.15$59.25 | −69.4% |
| Shares Outstanding (Basic) | 12.40M12.56M | −1.2% |
| Shares Outstanding (Diluted) | 12.45M12.60M | −1.2% |
05—Questions
Frequently Asked Questions
Why did net income fall so sharply in the third quarter of 2026?
The main driver was a net investment loss of $280.9 million in the quarter, compared with a gain of $432.9 million in the third quarter of 2025. Net investment gains and losses are primarily unrealized market value changes on equity securities. Net income also absorbed $74.6 million of net losses from the Middle East conflict in Markel Insurance's current accident year results.
What is the Middle East conflict's impact on Markel's results?
The company recorded $74.6 million of net losses and loss adjustment expenses for the quarter and $150.6 million for the nine months, attributed primarily to marine war, terrorism, and energy coverages written by the International division. The filing states that the impact on the Markel Insurance combined ratio was 3.4% for the quarter and 2.4% for the nine months. Management notes that additional losses may be incurred in subsequent periods and that they may be material.
What is the Enstar adverse development cover, and when will it close?
On October 27, 2026, Markel Insurance agreed to an adverse development cover with Cavello Bay Reinsurance Limited, a wholly-owned subsidiary of Enstar Group Limited. The agreement, effective April 1, 2026, covers $4.8 billion of subject reserves, with Markel retaining the first $2.6 billion and retroceding the next $2.3 billion, plus $1.2 billion of adverse development coverage for a $120 million risk premium. It is subject to regulatory approvals and is expected to close in the fourth quarter of 2026.
What caused the $205.3 million provision for expected credit losses?
The provision relates to reinsurance recoverables from one capacity provider in State National's program services fronting operations, which is currently in bankruptcy. After a second-quarter 2026 actuarial reserve assessment increased losses on the related programs, the company did not expect to obtain additional collateral, so it recognized the uncollateralized portion as an allowance for expected credit losses.
How much capital did Markel return to shareholders, and how much authorization remains?
The company repurchased $685.3 million of common stock in the first nine months of 2026, compared with $344.0 million in the same period of 2025. As of September 30, 2026, $832.6 million remained available under the Board's $2 billion share repurchase program, which has no expiration date.
06—Continue